MTMT-ben szereplő publikációk tallózása szerző szerint "SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika"

A találatok rendezése: Rendezés: Találatok:

  • Tissue transglutaminase ELISA positivity in autoimmune diseaseindependent of gluten-sensitive disease 
    Sárdy, Miklós; Medvecz, Márta; Geisen C; Preisz, Klaudia; Kornsee Z; Tomsits, Erika; Tox U; Hunzelmann N; Wieslander J; Kárpáti, Sarolta; Paulsson M; Smyth N (2007)
    Background: Our aim was to understand why some sera from patients with a broad spectrum of autoimmune diseases or non-autoimmune diseases involving enhanced apoptosis, cell lysis and/or putative secondary autoimmune processes ...
  • Tíz év, 600 vizsgálat - Gyermekek video-EEG- monitorizálásával szerzett tapasztalataink [10 years, 600 monitoring sessions--our experience with the video EEG monitoring of children] 
    Siegler Zsusza; Hegyi Márta; Jakus Rita; Neuwirth Magda; Paraicz Éva; Szabó, Léna; Fogarasi, András (2013)
  • Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies 
    Paris, Kenneth; Haddad, Elie; Borte, Michael; Brodszki, Nicholas; Dérfalvi, Beáta; Marodi, Laszlo; Hussain, Iftikhar; Darter, Amy; Engl, Werner; Leibl, Heinz; McCoy, Barbara; Yel, Leman (2019)
    Aim: To assess Ig20Gly tolerability in pediatric patients with primary immunodeficiencies. Patients & methods: Infusion parameters and tolerability were analyzed in pediatric patients (aged 2-5 years [n=6], 6-11 years ...
  • Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism. 
    Müller, Judit; Kralovánszky, Judit; Adleff V; Pap E; Németh, Krisztina; Komlósi, Lajos Viktor; Kovács, Gábor (2008)
    BACKGROUND: High-dose methotrexate (HD-MTX) is one of the most important agents in the therapy of osteosarcoma (OSC). Acute and delayed toxicities still constitute clinical problems. Methylenetetrahydrofolate reductase ...
  • TP53 mutation hits energy metabolism and increases glycolysis in breast cancer 
    Harami-Papp H; Pongor, Lőrinc; Munkacsy G; Horváth, Gergő; Nagy, Ádám Miklós; Ambrus, Attila; Hauser, Péter; Szabó, András; Tretter, László; Győrffy, Balázs (2016)
    Promising new hallmarks of cancer is alteration of energy metabolism that involves molecular mechanisms shifting cancer cells to aerobe glycolysis. Our goal was to evaluate the correlation between mutation in the commonly ...
  • TPMCalculator: one-step software to quantify mRNA abundance of genomic features. 
    Vera Alvarez, Roberto; Pongor, Lorinc Sandor; Mariño-Ramírez, Leonardo; Landsman, David (2019)
    The quantification of RNA sequencing (RNA-seq) abundance using a normalization method that calculates transcripts per million (TPM) is a key step to compare multiple samples from different experiments. TPMCalculator is a ...
  • Transcriptome evolution from breast epithelial cells to basallike tumors 
    Santpere G; Alcaráz-Sanabria A; Corrales-Sánchez V; Pandiella A; Győrffy, Balázs; Ocaña A (2018)
    In breast cancer, it is unclear the functional modifications at a transcriptomic level that are associated with the evolution from epithelial cells and ductal carcinoma in situ (DCIS) to basal-like tumors. By applying ...
  • Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors 
    Martínez-Canales S; Cifuentes F; De Rodas Gregorio ML; Serrano-Oviedo L; Galan-Moya EM; Amir E; Pandiella A; Győrffy, Balázs; Ocaña A (2017)
    Background: Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable ...
  • Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries 
    Fabian, Ido Didi; Stacey, Andrew W; Foster, Allen; Kivelä, Tero T; Munier, Francis L.; Keren-Froim, Naama; Gomel, Nir; Cassoux, Nathalie; Sagoo, Mandeep S; Reddy, M Ashwin; Harby, Lamis Al; Zondervan, Marcia; Bascaran, Covadonga; Abdallah, Elhassan; Abdullahi, Shehu U; Boubacar, Sahadatou Adamou; Ademola-Popoola, Dupe S; Adio, Adedayo; Aghaji, Ada E; Portabella, Silvia Alarcón; Alfa Bio, Amadou I; Ali, Amany M; Alia, Donjeta B; All-Eriksson, Charlotta; Almeida, Argentino A; Alsawidi, Khalifa M; Antonino, Romanzo; Astbury, Nicholas J; Atsiaya, Rose; Balaguer, Julia; Balwierz, Walentyna; Barranco, Honorio; Popovic, Maja Beck; Benmiloud, Sarra; Guebessi, Nissrine Bennani; Berete, Rokia C; Biddulph, Shelley J; Biewald, Eva M; Blum, Sharon; Bobrova, Nadia; Boehme, Marianna; Bornfeld, Norbert; Bouda, Gabrielle C; Bouguila, Hédi; Boumedane, Amaria; Brichard, Bénédicte G; l, Michael Capra; Castela, Guilherme; Català-Mora, Jaume; Chantada, Guillermo L; Chernodrinska, Violeta S; Chiwanga, Faraja S; Cieslik, Krzysztof; Comsa, Codruta; Correa Llano, Maria G; Csóka, Monika; Da Gama, Isac V; Davidson, Alan; Potter, Patrick De; Desjardins, Laurence; Dragomir, Monica D; Bruyn, Magritha Du; Kettani, Asmaa El; Elbahi, Amal M; Elgalaly, Dina; Elhaddad, Alaa M; Ali Elhassan, Moawia M; Elzembely, Mahmoud M; Essuman, Vera A; Evina, Ted Grimbert A; Fasina, Oluyemi; Fernández-Teijeiro, Ana; Gandiwa, Moira; Aldana, David García; Geel, Jennifer A; Gizachew, Zelalem; Gregersen, Pernille A; Guedenon, Koffi M; Hadjistilianou, Theodora; Hassan, Sadiq; Hederova, Stanislava; Hessissen, Laila; Hordofa, Diriba F; Hummlen, Marlies; Husakova, Kristina; Ida, Russo; Ilic, Vesna R; Jenkinson, Helen; Amani Kabesha, Theophile B; Kabore, Rolande L; Kalinaki, Abubakar; Kapelushnik, Noa; Kardava, Tamar; Kemilev, Pavlin Kroumov; Kepak, Tomas; Khotenashvili, Zaza; Klett, Artur; Kosh Komba Palet, Jess Elio; Krivaitiene, Dalia; Kruger, Mariana; Kyara, Alice; Lachmann, Eva S; Latinović, Slobodanka; Lecuona, Karin; Lukamba, Robert M; Lumbroso, Livia; Lysytsia, Lesia; Maka, Erika; Makan, Mayuri; Manda, Chatonda; Begue, Nieves Martín; Matende, Ibrahim O; Matua, Marchelo; Mayet, Ismail; Mbumba, Freddy B; Mengesha, Aemero A; Midena, Edoardo; Mndeme, Furahini G; Mohamedani, Ahmed A; Moll, Annette C; Moreira, Claude; Msina, Mchikirwa S; Msukwa, Gerald; Muma, Kangwa I; Murgoi, Gabriela; Musa, Kareem O; Mustak, Hamzah; Muyen, Okwen M; Naidu, Gita; Naumenko, Larisa; Ndoye Roth, Paule Aïda; Neroev, Vladimir; Nikitovic, Marina; Nkanga, Elizabeth D; Nkumbe, Henry; Nyaywa, Mutale; Obono-Obiang, Ghislaine; Oguego, Ngozi C; Olechowski, Andrzej; Oscar, Alexander Hugo; Osei-Bonsu, Peter; Painter, Sally L; Paintsil, Vivian; Paiva, Luisa; Papyan, Ruzanna; Parrozzani, Raffaele; Parulekar, Manoj; Pawinska-Wasikowska, Katarzyna; Perić, Sanja; Philbert, Remezo; Pochop, Pavel; Polyakov, Vladimir G; Pompe, Manca T; Pons, Jonathan J; Raobela, Léa; Renner, Lorna A; Reynders, David; Ribadu, Dahiru; Riheia, Mussagy M; Ritter-Sovinz, Petra; Saakyan, Svetlana; Said, Azza MA; Román Pacheco, Sonsoles San; Scanlan, Trish A; Schoeman, Judy; Seregard, Stefan; Sherief, Sadik T; Cheikh, Sidi Sidi; Silva, Sónia; Sorochynska, Tetyana; Ssali, Grace; Stathopoulos, Christina; Kranjc, Branka Stirn; Stones, David K; Svojgr, Karel; Sylla, Fatoumata; Tamamyan, Gevorg; Tandili, Alketa; Tateshi, Bekim; Theophile, Tuyisabe; Traoré, Fousseyni; Tyau-Tyau, Harba; Umar, Ali B; Urbak, Steen F; Ushakova, Tatiana L; Valeina, Sandra; Hoefen Wijsard, Milo van; Veleva-Krasteva, Nevyana V; Viksnins, Maris; Wackernagel, Werner; Waddell, Keith; Wade, Patricia D; Wali Nigeria, Amina H; Wime, Amelia DC; Dod, Charlotte Wolley; Yanga, Jenny M; Yarovaya, Vera A; Yarovoy, Andrey A; Zein, Ekhtelbenina; Sharabi, Shirley; Zhilyaeva, Katsiaryna; Ziko, Othman AO; Bowman, Richard (2021)
  • Treatment and outcome analysis of 639 relapsed non-hodgkin lymphomas in children and adolescents and resulting treatment recommendations 
    Burkhardt, B; Taj, M; Garnier, N; Minard-Colin, V; Hazar, V; Mellgren, K; Osumi, T; Fedorova, A; Myakova, N; Verdu-Amoros, J; Andres, M; Kabickova, E; Attarbaschi, A; Chiang, AKS; Bubanska, E; Donska, S; Hjalgrim, LL; Wachowiak, J; Pieczonka, A; Uyttebroeck, A; Lazic, J; Loeffen, J; Buechner, J; Niggli, F; Csóka, Monika; Kriván, Gergely; Palma, J; Amos, Burke GA; Beishuizen, A; Koeppen, K; Mueller, S; Herbrueggen, H; Woessmann, W; Zimmermann, M; Balduzzi, A; Pillon, M (2021)
    Despite poor survival, controversies remain in the treatment for refractory or relapsed pediatric non-Hodgkin lymphoma (r/r NHL). The current project aimed to collect international experience on the re-induction treatment ...
  • Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols 
    Müller, Judit; Csóka, Monika; Jakab, Zsuzsanna; Ponyi, Andrea; Erlaky, Hajna; Kovács, Gábor (2008)
    Retrospective analysis was performed to assess the survival-rates of children with non-Hodgkin lymphoma (NHL), treated according to the NHL-BFM (Berlin-Frankfurt-Munster)-90 and -95 protocols between 1990 and 2004 in ...
  • Trends and territorial inequalities of incidence and survival of childhood leukaemia and their relations to socioeconomic status in Hungary, 1971-2015 
    Jakab, Zsuzsanna; Juhasz A; Nagy C; Schuler, Dezső; Garami, Miklós; the Hungarian Paediatric Haemato-Oncology Network (2017)
    The Hungarian Childhood Cancer Registry, a population-based national registry of the Hungarian Paediatric Haemato-Oncology Network founded in 1971, monitors the incidence and mortality of childhood cancer. Our aims were ...
  • Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles 
    Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy, Balázs; Lawrence T; Dean DC; Postigo A (2017)
    Accumulation of tumor-associated macrophages (TAMs) associates with malignant progression in cancer. However, the mechanisms that drive the pro-tumor functions of TAMs are not fully understood. ZEB1 is best known for driving ...
  • Tünetmentes mononucleosis infectiosa szövődményeként kialakult spontán lépruptura 
    Szokó M; Matolcsy, András; Kovács, Gábor; Simon G (2007)
  • Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary. 
    Török, Dóra; Eckhardt G; Sólyom, János (2003)
    The aim of this study was to assess the effectivity of the identification of patients with congenital adrenal hyperplasia (CAH) in Hungary in the absence of systematic neonatal screening and to estimate the incidence. Dried ...
  • Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation 
    Fan J-B; Miyauchi-Ishida S; Arimoto K-I; Liu D; Yan M; Liu C-W; Győrffy, Balázs; Zhang D-E (2015)
    Type I IFNs have broad activity in tissue inflammation and malignant progression that depends on the expression of IFN-stimulated genes (ISGs). ISG15, one such ISG, can form covalent conjugates to many cellular proteins, ...
  • UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients 
    Madreiter-Sokolowski CT; Győrffy, Balázs; Klec C; Sokolowski AA; Rost R; Waldeck-Weiermair M; Malli R; Graier WF (2017)
    Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca2+-triggered high mitochondrial activity. But mitochondrial Ca2+ uptake has to be strictly ...
  • Újabb adatok a gyulladásos izombetegségekről 
    Dankó Katalin; Ponyi, Andrea; Constantin, Tamás (2006)
  • Új és hagyományos irányok a gyermekkori akut lymphoblastos leukaemia biológiájában és ellátásában 
    Egyed B; Kovács, Gábor; Kutszegi, Nóra; Rzepiel A; C. Sági, Judit; Erdélyi, Dániel; Müller, Judit; Semsei, Ágnes F (2018)
    Owing to clinical trials and improvement over the past few decades, the majority of children with acute lymphoblastic leukemia (ALL) survive by first-line chemotherapy and combat with the problems of returning to community. ...
  • Új lehetőségek a gyermekkori lymphomák kezelésében 
    Kovács, Gábor; Csóka, Monika (2010)